Results 111 to 120 of about 29,991,998 (211)
Le BHV-1 est un herpesvirus touchant presque exclusivement les bovins et dont la prévalence est très variable selon les pays. L'épidémiologie virale est très fortement marquée par le phénomène de latence virale : un animal contaminé reste porteur à vie ...
BLANC, Rodolphe +1 more
core
In this study, blood samples taken from 143 bulls choosen bulls that using in artificial insemination centers were investigated for antibodies against BHV-1, BVDV and EBLV infections by ELISA/Ab. It was determined as positive that antibodies against 12 bulls (8.3%) for BHV-1, 25 bulls (17.4%) for BVDV and 14 bulls (9.7%) for EBLV.
Orhan Yapkıç +5 more
openaire +1 more source
Analysis of virus host interactions following infection with bovine herpesvirus 1 (BHV-1)
Bovine herpesvirus 1 (BHV-1) is an important pathogen of cattle that causes respiratory and reproductive disease. BHV-1 induces latency in sensory ganglia that innervate the site of primary infection.
Lovato, Luciane Teresinha
core
Bovine Adenovirus 3-Based Viral Vectors for Veterinary Vaccine Development: Progress, Limitations, and Future Directions. [PDF]
Sthitmatee N, Varinrak T, Kreausukon K.
europepmc +1 more source
Admission low-density lipoprotein cholesterol and early haematoma expansion after spontaneous intracerebral haemorrhage. [PDF]
Wang G +5 more
europepmc +1 more source
Pyriphenone modification of glutaraldehyde pretreated bovine pericardium mitigates advanced glycation end products, calcification, and platelet adhesion. [PDF]
Zakharchenko A +12 more
europepmc +1 more source
Bovine herpesvirus type 1 (BHV-1) is a pathogen of cattle that establishes latency primarily in trigeminal ganglia (TG). The latency-related (LR) gene is abundantly expressed at this stage.
Perez de Bretschneider, Sandra Elizabeth
core
Immediate post-injury HMGB1 neutralization prevents synaptic dysfunction in burn and hindlimb unloaded rats. [PDF]
Sreenivasa Murthy SGS +7 more
europepmc +1 more source
Alpha-gal xenoantigens in bioprosthetic valve recipients: clinical implications for bioprosthesis longevity. [PDF]
Gosden J +4 more
europepmc +1 more source

